In the last 12 months, insiders at Cadrenal Therapeutics, Inc. ($CVKD) filed 61 transactions with the SEC: 11 open-market purchases totaling $161,404 and 23 sales totaling $709,811. Net insider sentiment: net selling.
Cadrenal Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Pham Quang X (CEO and Chairman) — 23 transactions totaling $460,989
- Szot Matthew K (Chief Financial Officer) — 15 transactions totaling $397,455
- MURPHY JOHN RAYMOND (Director) — 8 transactions totaling $61,271
- Zelenkofske Steven (Director) — 2 transactions totaling $0
- Pham Quang X (Chief Executive Officer) — 1 transaction totaling $0
View all SEC Filings for Cadrenal Therapeutics, Inc. (CVKD).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 29, 2025 | Szot Matthew K | Chief Financial Officer | S | Common Stock | 9933 | $6.97 | 0.0000 | 2,044,033 | 100.00% | 0.49% |
| Dec. 2, 2025 | Golden Lee Scott | Director | A | Stock Options | 5000 | $0.00 | 5,000.0000 | 2,044,033 | 9999.99% | 0.24% |
| Oct. 24, 2025 | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1800 | $13.99 | 11,733.0000 | 2,044,033 | 13.30% | 0.09% |
| Oct. 27, 2025 | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1800 | $13.99 | 9,933.0000 | 2,044,033 | 15.34% | 0.09% |
| Oct. 24, 2025 | Pham Quang X | CEO and Chairman | S | Common Stock | 1129 | $14.03 | 397,404.0000 | 2,044,033 | 0.28% | 0.06% |
| Oct. 27, 2025 | Pham Quang X | CEO and Chairman | S | Common Stock | 1315 | $13.99 | 396,089.0000 | 2,044,033 | 0.33% | 0.06% |
| Oct. 13, 2025 | Pham Quang X | CEO and Chairman | S | Common Stock | 1800 | $14.15 | 398,533.0000 | 2,044,033 | 0.45% | 0.09% |
| Oct. 13, 2025 | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1800 | $14.07 | 13,533.0000 | 2,044,033 | 11.74% | 0.09% |
| Oct. 9, 2025 | Pham Quang X | CEO and Chairman | S | Common Stock | 1800 | $14.02 | 400,333.0000 | 2,044,033 | 0.45% | 0.09% |
| Oct. 9, 2025 | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1693 | $13.99 | 15,333.0000 | 2,044,033 | 9.94% | 0.08% |
| Oct. 6, 2025 | Szot Matthew K | Chief Financial Officer | S | Common Stock | 107 | $13.99 | 17,026.0000 | 2,044,033 | 0.62% | 0.01% |
| Oct. 2, 2025 | Pham Quang X | CEO and Chairman | S | Common Stock | 500 | $14.13 | 402,133.0000 | 2,044,033 | 0.12% | 0.02% |
| Sept. 29, 2025 | Pham Quang X | CEO and Chairman | S | Common Stock | 419 | $14.01 | 403,514.0000 | 1,961,642 | 0.10% | 0.02% |
| Oct. 1, 2025 | Pham Quang X | CEO and Chairman | S | Common Stock | 881 | $14.01 | 402,633.0000 | 2,044,033 | 0.22% | 0.04% |
| Sept. 29, 2025 | Szot Matthew K | Chief Financial Officer | S | Common Stock | 100 | $14.00 | 18,833.0000 | 1,961,642 | 0.53% | 0.01% |
| Oct. 1, 2025 | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1700 | $13.99 | 17,133.0000 | 2,044,033 | 9.03% | 0.08% |
| Sept. 24, 2025 | Pham Quang X | CEO and Chairman | S | Common Stock | 2581 | $13.99 | 410,723.0000 | 1,961,642 | 0.62% | 0.13% |
| Sept. 25, 2025 | Szot Matthew K | Chief Financial Officer | S | Common Stock | 10900 | $14.05 | 18,933.0000 | 1,961,642 | 36.54% | 0.56% |
| Sept. 24, 2025 | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1500 | $14.00 | 29,833.0000 | 1,961,642 | 4.79% | 0.08% |
| Sept. 25, 2025 | Pham Quang X | CEO and Chairman | S | Common Stock | 6790 | $14.09 | 403,933.0000 | 1,961,642 | 1.65% | 0.35% |
| Aug. 28, 2025 | Pham Quang X | CEO and Chairman | S | Common Stock | 1193 | $13.99 | 413,304.0000 | 1,961,642 | 0.29% | 0.06% |
| Aug. 27, 2025 | Szot Matthew K | Chief Financial Officer | S | Common Stock | 1600 | $14.00 | 31,733.0000 | 1,961,642 | 4.80% | 0.08% |
| Aug. 28, 2025 | Szot Matthew K | Chief Financial Officer | S | Common Stock | 400 | $14.00 | 31,333.0000 | 1,961,642 | 1.26% | 0.02% |
| Aug. 27, 2025 | Pham Quang X | CEO and Chairman | S | Common Stock | 3836 | $13.99 | 414,497.0000 | 1,961,642 | 0.92% | 0.20% |
| Jan. 23, 2025 | Pham Quang X | CEO and Chairman | A | Stock Options | 65000 | $0.00 | 65,000.0000 | 1,219,550 | 9999.99% | 5.33% |
| Feb. 5, 2025 | Ferguson James J. III | Chief Medical Officer | A | Stock Options | 60000 | $0.00 | 60,000.0000 | 1,219,550 | 9999.99% | 4.92% |
| Jan. 23, 2025 | WILSON GLYNN | Director | A | Stock Options | 20000 | $0.00 | 20,000.0000 | 1,219,550 | 9999.99% | 1.64% |
| Jan. 23, 2025 | Zelenkofske Steven | Director | A | Stock Options | 20000 | $0.00 | 20,000.0000 | 1,219,550 | 9999.99% | 1.64% |
| Jan. 23, 2025 | Cole Jeffrey Scott | Chief Operating Officer | A | Stock Options | 25000 | $0.00 | 25,000.0000 | 1,219,550 | 9999.99% | 2.05% |
| Jan. 23, 2025 | Szot Matthew K | Chief Financial Officer | A | Stock Options | 50000 | $0.00 | 50,000.0000 | 1,219,550 | 9999.99% | 4.10% |
| Jan. 23, 2025 | Pham Quang X | CEO and Chairman | A | Stock Options | 65000 | $0.00 | 65,000.0000 | 1,219,550 | 9999.99% | 5.33% |
| Jan. 23, 2025 | MURPHY JOHN RAYMOND | Director | A | Stock Options | 20000 | $0.00 | 20,000.0000 | 1,219,550 | 9999.99% | 1.64% |
| Jan. 23, 2025 | Lisicki Robert | Director | A | Stock Options | 20000 | $0.00 | 20,000.0000 | 1,219,550 | 9999.99% | 1.64% |
| April 10, 2024 | Pham Quang X | CEO and Chairman | G | Common Stock | 50000 | $0.00 | 6,275,000.0000 | 1,067,231 | 0.79% | 4.69% |
| April 2, 2024 | Cole Jeffrey Scott | Chief Operating Officer | A | Stock Options | 150000 | $0.00 | 150,000.0000 | 1,067,231 | 9999.99% | 14.06% |
| Oct. 23, 2023 | Pham Quang X | CEO and Chairman | G | Common Stock | 85000 | $0.00 | 6,325,000.0000 | 1,026,415 | 1.33% | 8.28% |
| Jan. 18, 2024 | Szot Matthew K | Chief Financial Officer | A | Stock Options | 250000 | $0.00 | 250,000.0000 | 899,465 | 9999.99% | 27.79% |
| Jan. 18, 2024 | Pham Quang X | Chief Executive Officer | A | Stock Options | 150000 | $0.00 | 150,000.0000 | 899,465 | 9999.99% | 16.68% |
| Jan. 18, 2024 | Lisicki Robert | Director | A | Stock Options | 50000 | $0.00 | 50,000.0000 | 899,465 | 9999.99% | 5.56% |
| Jan. 18, 2024 | LOSORDO DOUGLAS W | Chief Medical Officer | A | Stock Options | 150000 | $0.00 | 150,000.0000 | 899,465 | 9999.99% | 16.68% |
| Jan. 18, 2024 | WILSON GLYNN | Director | A | Stock Options | 70000 | $0.00 | 70,000.0000 | 899,465 | 9999.99% | 7.78% |
| Jan. 18, 2024 | MURPHY JOHN RAYMOND | Director | A | Stock Options | 100000 | $0.00 | 100,000.0000 | 899,465 | 9999.99% | 11.12% |
| Jan. 18, 2024 | Zelenkofske Steven | Director | A | Stock Options | 100000 | $0.00 | 100,000.0000 | 899,465 | 9999.99% | 11.12% |
| Oct. 4, 2023 | MURPHY JOHN RAYMOND | Director | P | Common Stock | 17331 | $0.70 | 612,123.0000 | 1,026,415 | 2.91% | 1.69% |
| Oct. 5, 2023 | MURPHY JOHN RAYMOND | Director | P | Common Stock | 2669 | $0.69 | 614,792.0000 | 1,026,415 | 0.44% | 0.26% |
| Sept. 5, 2023 | Pham Quang X | CEO and Chairman | P | Common Stock | 20000 | $0.90 | 6,410,000.0000 | 11,722,754 | 0.31% | 0.17% |
| Sept. 5, 2023 | Pham Quang X | CEO and Chairman | P | Common Stock | 20000 | $0.91 | 6,390,000.0000 | 11,722,754 | 0.31% | 0.17% |
| Sept. 1, 2023 | Pham Quang X | CEO and Chairman | P | Common Stock | 10000 | $0.84 | 6,370,000.0000 | 11,722,754 | 0.16% | 0.09% |
| Sept. 1, 2023 | Pham Quang X | CEO and Chairman | P | Common Stock | 10000 | $0.93 | 6,310,000.0000 | 11,722,754 | 0.16% | 0.09% |
| Sept. 1, 2023 | Pham Quang X | CEO and Chairman | P | Common Stock | 20000 | $0.93 | 6,330,000.0000 | 11,722,754 | 0.32% | 0.17% |
| Sept. 1, 2023 | Pham Quang X | CEO and Chairman | P | Common Stock | 20000 | $0.92 | 6,350,000.0000 | 11,722,754 | 0.32% | 0.17% |
| Sept. 1, 2023 | Pham Quang X | CEO and Chairman | P | Common Stock | 10000 | $0.92 | 6,360,000.0000 | 11,722,754 | 0.16% | 0.09% |
| July 23, 2023 | Lisicki Robert | Director | A | Stock options | 75000 | $0.00 | 75,000.0000 | 11,722,754 | 9999.99% | 0.64% |
| March 21, 2023 | MURPHY JOHN RAYMOND | Director | P | Common Stock | 10000 | $1.39 | 594,792.0000 | 7,890,507 | 1.71% | 0.13% |
| March 16, 2023 | MURPHY JOHN RAYMOND | Director | P | Common Stock | 20000 | $1.67 | 574,792.0000 | 7,890,507 | 3.60% | 0.25% |
| Feb. 10, 2023 | Pham Quang X | CEO and Chairman | A | Common Stock | 25000 | $1.94 | 6,300,000.0000 | 7,890,507 | 0.40% | 0.32% |
| Jan. 24, 2023 | WILSON GLYNN | Director | C | Common Stock | 50000 | $0.00 | 50,000.0000 | 7,890,507 | 9999.99% | 0.63% |
| Jan. 24, 2023 | MURPHY JOHN RAYMOND | Director | C | Convertible Promissory Note | 514792 | $0.00 | 0.0000 | 7,890,507 | 100.00% | 6.52% |
| Jan. 24, 2023 | WILSON GLYNN | Director | C | Convertible Promissory Note | 50000 | $0.00 | 0.0000 | 7,890,507 | 100.00% | 0.63% |
| Jan. 24, 2023 | Szot Matthew K | Chief Financial Officer | A | Common Stock | 50000 | $0.00 | 500,000.0000 | 7,890,507 | 11.11% | 0.63% |
| Jan. 24, 2023 | MURPHY JOHN RAYMOND | Director | C | Common Stock | 514792 | $0.00 | 554,792.0000 | 7,890,507 | 1286.98% | 6.52% |